The Combination of Rituximab and Bendamustine as First-Line Treatment Is Highly Effective in the Eradicating Minimal Residual Disease in Follicular Lymphoma: An Italian Retrospective Study

R-Bendamustine is an effective treatment for follicular lymphoma (FL). Previous large trials demonstrated the prognostic role of the molecular minimal residual disease (MRD) during the most frequently adopted chemotherapeutic regimens, but there are not yet conclusive data about the effect of combin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Pharmacol
Hoofdauteurs: Galimberti, Sara, Ciabatti, Elena, Ercolano, Giacomo, Grassi, Susanna, Guerrini, Francesca, Cecconi, Nadia, Rousseau, Martina, Cervetti, Giulia, Mazziotta, Francesco, Iovino, Lorenzo, Falzetti, Franca, Falcinelli, Flavio, Bosi, Alberto, Rigacci, Luigi, Kovalchuk, Sofia, Vallisa, Daniele, Macchia, Lucia, Ciancia, Eugenio, Petrini, Mario
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2017
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489595/
https://ncbi.nlm.nih.gov/pubmed/28706485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00413
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items